Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy

Abstract Purpose The body mass index (BMI) is commonly used as a simple indicator of obesity; patients with early-stage breast cancer who are obese (OB) per BMI measurements have been shown to have high postoperative recurrence and low survival rates. On the other hand, it has been shown that lympho...

Full description

Bibliographic Details
Main Authors: Koji Takada, Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Sae Ishihara, Tamami Morisaki, Masatsune Shibutani, Hiroaki Tanaka, Kosei Hirakawa, Masaichi Ohira
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
Breast cancer
Body mass index
Tumor-infiltrating lymphocytes
Preoperative chemotherapy
Tumor immune microenvironment
Online Access:https://doi.org/10.1186/s12885-021-08857-7

Internet

https://doi.org/10.1186/s12885-021-08857-7

Similar Items